Pharma Journalist 8947 posts 0 comments

Eli Lilly and Company announced that Emgality (galcanezumab-gnlm) met the primary and all key secondary outcomes in CONQUER, a Phase 3 study evaluating the efficacy and safety of…
Read More...

HCL Technologies (HCL), a leading global technology company and a Platinum-Level member of Oracle Partner Network (OPN), and Oracle Health Sciences announced a collaboration to help…
Read More...

Neuropore Therapies, Inc. announced that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative diseases which were…
Read More...

Foamix Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in…
Read More...

Sosei Group Corporation announces that it has entered into a strategic multi-target partnership with Takeda Pharmaceutical Company Limited, to discover, develop and commercialize novel…
Read More...

Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for givosiran, an investigational RNAi…
Read More...

2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019 “Securing your Supply Chain and Quality Management” 19th September 2019, Kohinoor Continental Hotel,…
Read More...

Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) approved TURALIO (pexidartinib) as the first and only treatment…
Read More...

Omeros Corporation announced a long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding…
Read More...